SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Elan D. Louis, Claire Henchcliffe, Brian T. Bateman, H. Christian Schumacher, Young-onset Parkinson's disease: Hospital utilization and medical comorbidity in a nationwide survey, Movement Disorders, 2015, 30, 7
  2. 2
    R. García-Ramos, E. López Valdés, L. Ballesteros, S. Jesús, P. Mir, Informe de la Fundación del Cerebro sobre el impacto social de la enfermedad de Parkinson en España, Neurología, 2013,

    CrossRef

  3. 3
    R. Gènova-Maleras, E. Álvarez-Martín, C. Morant-Ginestar, N. Fernández de Larrea-Baz, F. Catalá-López, Measuring the burden of disease and injury in Spain using disability-adjusted life years: An updated and policy-oriented overview, Public Health, 2012, 126, 12, 1024

    CrossRef

  4. 4
    Carmen Dyck, Susan Calne, Parkinson's Disease, Second Edition, 2012,

    CrossRef

  5. 5
    Anders Gustavsson, Mikael Svensson, Frank Jacobi, Christer Allgulander, Jordi Alonso, Ettore Beghi, Richard Dodel, Mattias Ekman, Carlo Faravelli, Laura Fratiglioni, Brenda Gannon, David Hilton Jones, Poul Jennum, Albena Jordanova, Linus Jönsson, Korinna Karampampa, Martin Knapp, Gisela Kobelt, Tobias Kurth, Roselind Lieb, Mattias Linde, Christina Ljungcrantz, Andreas Maercker, Beatrice Melin, Massimo Moscarelli, Amir Musayev, Fiona Norwood, Martin Preisig, Maura Pugliatti, Juergen Rehm, Luis Salvador-Carulla, Brigitte Schlehofer, Roland Simon, Hans-Christoph Steinhausen, Lars Jacob Stovner, Jean-Michel Vallat, Peter Van den Bergh, Jim van Os, Pieter Vos, Weili Xu, Hans-Ulrich Wittchen, Bengt Jönsson, Jes Olesen, Cost of disorders of the brain in Europe 2010, European Neuropsychopharmacology, 2011, 21, 10, 718

    CrossRef

  6. 6
    Zivar Salehi, Farzad Rajaei, Expression of hepatocyte growth factor in the serum and cerebrospinal fluid of patients with Parkinson’s disease, Journal of Clinical Neuroscience, 2010, 17, 12, 1553

    CrossRef

  7. 7
    Samyra H.J. Keus, Marten Munneke, Maarten J. Nijkrake, Gert Kwakkel, Bastiaan R. Bloem, Physical therapy in Parkinson's disease: Evolution and future challenges, Movement Disorders, 2009, 24, 1
  8. 8
    A. Villaverde-Hueso, M. Posada de la Paz, M. C. Martín-Arribas, E. Sánchez-Valle, A. Ramírez-González, P. Biairdi, Prevalence of scleroderma in Spain: an approach for estimating rare disease prevalence using a disease model, Pharmacoepidemiology and Drug Safety, 2008, 17, 11
  9. 9
    Gang Wang, Qi Cheng, Rui Zheng, Yu-Yan Tan, Xiao-Kang Sun, Hai-Yan Zhou, Xiao-Lai Ye, Ying Wang, Zeng Wang, Bo-Min Sun, Sheng-Di Chen, Economic burden of Parkinson's disease in a developing country: A retrospective cost analysis in Shanghai, China, Movement Disorders, 2006, 21, 9